---
$id: https://graph.org.ai/products/commodity/51281642
$type: Product
source: UNSPSC
code: "51281642"
title: "Capreomycin iib"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Capreomycin iib

**UNSPSC Code**: 51281642
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula C19H32N12O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K630580G1N, chemically known as cyclo((2s)-2-amino-.beta.-alanyl-l-alanyl-3-amino-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl), but more generally known as capreomycin iib, which bears US NIH Compound Identifier 3034237. European Medicines Agency schedules capreomycin iib or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01028MIG. Most nations, for tariff purposes, schedule capreomycin iib under HS 29419000. SMILES: C[C@H]1C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CN.

